Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Immunotec Inc. IMMTF


Primary Symbol: V.IMM

Consumer Defensive Packaged Foods
"Immunotec Inc develops, manufactures, markets and sells research-driven nutritional products through direct-to-consumer sales channels in Canada, the United States, the Dominican Republic and Mexico."


TSXV:IMM - Post by User

Immunotec Inc.
Bullboard Posts
User Avatar Image
(0)
•••
Post by louon Jan 25, 2000 3:40pm
354 Views
Post# 1274020

Vancouver Sun article

Vancouver Sun article Anyone read the Sun today? On page: A4 "IBC study examines Alzheimer's, leprosy drug treament link" Some good background on how dapsone got looked at for Alzheimers, and IMM's plans for it, a couple quotes from Ron Kertesz. Anyone have a site link, maybe the article is there for folks outside vancouver. cheers lou
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities